ALEXANDRIA, Va., April 9 -- United States Patent no. 12,269,792, issued on April 8, was assigned to GENIE LIFESCIENCES INC. (Palo Alto, Calif.).

"Crystalline 5-(dimethylamino)-N-(4-(morpholinomethyl) phenyl)naphthalene-1-sulfonamide di-hydrochloride di-hydrate" was invented by Adam Galan (Alameda, Calif.), Ritu Lal (Palo Alto, Calif.) and Wendy Luo (Palo Alto, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Crystalline 5-(dimethylamino)-N-(4-(morpholinomethyl)phenyl)naphthalene-1-sulfonamide dihydrochloride dihydrate, methods of preparing the crystalline salt, pharmaceutical compositions containing the crystalline salt, and methods of treatment using the crystalline salt are disclosed."

The patent was...